BTIG Initiates Coverage On Serina Therapeutics with Buy Rating, Announces Price Target of $8

BTIG analyst Thomas Shrader initiates coverage on Serina Therapeutics (AMEX: SER ) with a Buy rating and announces Price Target of $8.